🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hyperlipoproteinemia (a)

Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH) NCT07447648n/a13 sites📍 Paris📍 Caserta📍 Catania Fondazione SISA (Societa Italiana per lo Studio della Arter… Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT NCT07720232Phase 41 site📍 Xiamen Jianyin Zhou · Tests: Live Combined Bacillus subtilis and Enterococcus faecium Enteric-coated Capsules (LCBE), Standard Care (in control arm) WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study NCT06752772NA1 site📍 Singapore Alexandra Hospital · Tests: Smart watch, Dashboard with nudging system, Digital Health Coach (DHC) Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia NCT04209244NA4 sites📍 Aalborg📍 Aarhus📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Eskimo-3 Pure Fish Oil, Rapeseed Oil A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia NCT06568471Phase 318 sites📍 Beijing📍 Beijing📍 Beijing Hasten Biopharmaceutical Co., Ltd. · Tests: Lerodalcibep, matching placebo Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia NCT06597019Phase 366 sites📍 San Francisco📍 San Francisco📍 Washington D.C. Novartis Pharmaceuticals · Tests: Inclisiran, Placebo A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis NCT05646381Phase 2140 sites📍 Huntsville📍 Beverly Hills📍 Beverly Hills Novartis Pharmaceuticals · Tests: Pelacarsen (TQJ230) 80mg, Matching placebo Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis NCT05860569Phase 11 site📍 Beijing GeneCradle Inc · Tests: GC304 A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia NCT07230730Phase 31 site📍 Hangzhou Beijing Suncadia Pharmaceuticals Co., Ltd · Tests: SHR-1918, SHR-1918 placebo Regional Innovation in Chronic Disease and Elderly Care NCT07578090n/a1 site📍 New Taipei City Fu Jen Catholic University A Study of SRSD216 in Patients With Elevated Lipoprotein (a) NCT07172646Phase 1, Phase 21 site📍 Beijing Sirius Therapeutics Co., Ltd. · Tests: SRSD216 injection, Placebo A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia NCT07799688Phase 22 sites📍 Jinan📍 Shanghai Fujian Shengdi Pharmaceutical Co., Ltd. · Tests: HRS-7249 Injection, HRS-7249 Injection A Study to Evaluate COR-1004 in Adult Volunteers. NCT07229118Phase 12 sites📍 Christchurch📍 Wellington Corsera Health · Tests: COR-1004, Placebo Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia NCT05816343Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Orlistat, Placebo National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry NCT06546137n/a27 sites📍 Rio Branco📍 Maceió📍 Macapá Hospital do Coracao · Tests: whole genome sequencing Atlantic Lipid Lowering Treatment Optimization Program NCT06439654NA2 sites📍 Clark📍 Springfield Atlantic Health System · Tests: Supportive care A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias NCT07491172Phase 117 sites📍 Hialeah📍 Jacksonville📍 Orlando CRISPR Therapeutics AG · Tests: CTX310 Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food NCT06988462NA1 site📍 Sommerville Cambridge Health Alliance · Tests: Bottarga, Comparator A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease NCT06164730Phase 127 sites📍 Dothan📍 Pomona📍 Boca Raton Verve Therapeutics, Inc. · Tests: VERVE-102 A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia NCT07421297Phase 32 sites📍 Beijing📍 Beijing CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Tests: SYH2053 injection, SYH2053 injection placebo Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia NCT07662330NA1 site📍 Shanghai Shanghai 10th People's Hospital · Tests: Spermidine, Placebo A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia NCT07229937Phase 21 site📍 Harbin Shandong Suncadia Medicine Co., Ltd. · Tests: HRS-1301, HRS-1301, HRS-1301, HRS-1301, Placebo Preventative Screening and Health Coaching in a Food Insecure Population NCT06907524NA1 site📍 Chicago Rush University Medical Center · Tests: Longitudinal, Individualized Health Coaching Cardiovascular Risk in Children With Chronic Conditions Study NCT07086989n/a3 sites📍 Budapest📍 Budapest📍 Budapest Semmelweis University Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis NCT06535542NA1 site📍 Abu Dhabi Abu Dhabi Health Services Company · Tests: Whole Genome Sequencing A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia NCT07695597Phase 21 site📍 Hangzhou CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · Tests: SYH2070, Placebo Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance NCT06684106NA2 sites📍 Xi'an📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: Ursodeoxycholic acid (UDCA) 500 mg, Placebo A Dose-exploration Study of EDP167 in HoFH NCT07489209Phase 21 site📍 Beijing Eddingpharm (Zhuhai) Co., Ltd. · Tests: EDP167 A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab NCT07543731n/a1 site📍 Basel Novartis Pharmaceuticals Evaluation of the Effects of Two Dietary Supplement Formulations on the Lipid Profile in Mild Hypercholesterolemia NCT06810466NA1 site📍 Bologna IBSA Farmaceutici Italia Srl · Tests: Test Product A, Test Product B, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy